| Name | PF-06648671 |
|---|
| Description | PF-06648671 (PF6648671) is a novel oral γ-secretase modulator being developed for the treatment of Alzheimer's disease. Alzheimer Disease Phase 1 Discontinued |
|---|---|
| References | References View Related Products by Target γ-secretase Alzheimer Disease |
| Molecular Formula | C25H23ClF4N4O3 |
|---|---|
| Molecular Weight | 538.928 |